MedPath

Etanercept

Generic Name
Etanercept
Brand Names
Enbrel, Eticovo, Benepali, Erelzi, Nepexto
Drug Type
Biotech
CAS Number
185243-69-0
Unique Ingredient Identifier
OP401G7OJC

Overview

Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of 934 amino acids. It is used to treat or manage a variety of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis (AS), and juvenile idiopathic poly-articular arthritis (JIA).

Indication

Etanercept is indicated for the treatment of moderately to severely active rheumatoid arthritis in adults and in chronic moderate to severe plaque psoriasis in patients 4 years of age and older. It is also used to manage signs and symptoms of polyarticular idiopathic arthritis and Juvenile Psoriatic Arthritis in those aged 2 years and older. Etanercept is also used to manage the symptoms of psoriatic arthritis and ankylosing spondylitis.

Associated Conditions

  • Active Juvenile Psoriatic Arthritis
  • Ankylosing Spondylitis (AS)
  • Graft-versus-host Disease (GVHD)
  • Polyarticular Juvenile Idiopathic Arthritis
  • Psoriasis Vulgaris (Plaque Psoriasis)
  • Psoriatic Arthritis
  • Pyoderma Gangrenosum
  • Rheumatoid Arthritis
  • Severe Plaque psoriasis
  • Stevens-Johnson Syndrome
  • Chronic, severe Psoriatic Arthritis
  • Moderate Plaque psoriasis
  • Moderate, active Rheumatoid arthritis
  • Severe, active Rheumatoid arthritis

Research Report

Published: Jul 16, 2025

Etanercept (DB00005): A Comprehensive Monograph on a Pioneering TNF Inhibitor

Section 1: Molecular Profile and Bioengineering

Etanercept is a cornerstone biologic agent in the treatment of autoimmune diseases, representing a triumph of rational drug design and recombinant DNA technology. Its structure and production method are intricately linked to its therapeutic efficacy, stability, and clinical utility.

1.1. Structural Characterization: An Engineered Dimeric Fusion Protein

Etanercept is a large, complex biomolecule classified as a dimeric fusion protein.[1] It possesses an apparent molecular weight of approximately 150 kilodaltons (kDa) and is composed of two identical polypeptide chains, with each chain comprising 934 amino acids.[1] The defining characteristic of Etanercept is its engineered structure, which is not found in nature. It is created by fusing two distinct and functionally critical human protein domains using recombinant DNA techniques.[5]

The two key components of each polypeptide chain are:

Continue reading the full research report

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

Title
Posted
Study ID
Phase
Status
Sponsor
2019/01/03
Phase 1
Terminated
2018/12/19
Phase 3
Terminated
2018/12/19
Phase 2
Completed
2018/11/02
Phase 3
Recruiting
2018/08/28
Phase 4
Completed
P. Verschueren
2018/08/17
Phase 4
Terminated
2018/04/20
Phase 4
UNKNOWN
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2018/03/02
Phase 3
Active, not recruiting
2018/01/30
Phase 3
Recruiting
2018/01/18
Phase 3
UNKNOWN

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

View More Health Canada Approvals

Sign in to access additional Health Canada approved drug information with detailed regulatory data.

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

View More CIMA AEMPS Approvals

Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

View More Philippines FDA Approvals

Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

View More Saudi SFDA Approvals

Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

View More Malaysia NPRA Approvals

Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

View More UK EMC Drug Information

Sign in to access additional UK EMC drug information with detailed pharmaceutical data.

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.